INT336382

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.08
First Reported 2011
Last Reported 2011
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.76
Pain Relevance 0.23

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (ZGLP1)
ZGLP1 (Homo sapiens)
Pain Link Frequency Relevance Heat
agonist 3 98.98 Very High Very High Very High
Neurotransmitter 2 83.20 Quite High
Inflammation 160 74.96 Quite High
dopamine receptor 1 58.24 Quite High
antagonist 1 52.56 Quite High
Endocannabinoid 5 51.76 Quite High
addiction 1 50.24 Quite High
Serotonin 2 35.44 Quite Low
Inflammatory response 12 5.00 Very Low Very Low Very Low
cINOD 9 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 15 98.12 Very High Very High Very High
Appetite Loss 8 98.12 Very High Very High Very High
INFLAMMATION 180 74.96 Quite High
Obesity 109 71.64 Quite High
Pressure And Volume Under Development 3 25.20 Quite Low
Myocardial Infarction 5 13.72 Low Low
Pain 11 5.00 Very Low Very Low Very Low
Insulin Resistance 10 5.00 Very Low Very Low Very Low
Chronic Disease 8 5.00 Very Low Very Low Very Low
Metabolic Syndrome 7 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Two diabetic drugs, exenatide (a GLP-1 receptor agonist) and sitagliptin (an inhibitor of the enzyme that degrades GLP-1) have demonstrated the potential for inducing weight loss.
Protein_catabolism (degrades) of GLP-1 associated with appetite loss, diabetes mellitus and agonist
1) Confidence 0.08 Published 2011 Journal Journal of Obesity Section Body Doc Link PMC2952901 Disease Relevance 0.76 Pain Relevance 0.23

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox